AMAT
Outperforming without a clear catalyst yet
- AMAT +2.03% on the last session vs SPY +0.74%: +1.3 pts of stock-specific move.
- Aftermath, big gain (Sep 29): After its 62 big gains in the past 5 years, AMAT typically gained 4.9% over the next month (median) and was higher 60% of the time; half the outcomes fell between -6.3% and +12.9%. An ordinary month: +2.3%. Among S&P 500 stocks after big gains, that ranks #117 of 500.
- 0 Reddit mentions in the past 24 hours, 75% positive over the week.
- 1 analyst action in the past 10 days (0 positive, 1 negative); latest: Morgan Stanley maintained Equal-Weight, lowered target $642 → $563.
- 1 insider or congressional trade in the past 30 days, including 1 insider sale not under a 10b5-1 plan.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
After each kind of event
| Event | Events | 1 day | 1 week | 1 month | 1 quarter |
|---|---|---|---|---|---|
| Any day | 1,255 | +0.1%#115 H | +0.7%#51 H | +2.3%#75 H | +8.0%#69 M |
| Big drop (-3.4% or worse) | 64 | +0.6%#68 H | +0.7%#210 H | +6.5%#19 H | +13.5%#103 M |
| Big gain Sep 29 (+4.1% or better) | 65 | -0.1%#339 H | +1.0%#112 H | +4.9%#117 H | +12.5%#96 M |
| Earnings beat | 18 | +1.1%#70 M | -0.3%#409 M | +1.1%#260 M | +6.4%#50 M |
| Earnings miss | 2 | +0.8%– | +6.7%– | -5.2%– | -9.0%– |
| 52-week high | 19 | +0.2%#175 M | -1.1%#423 M | +6.8%#19 M | +14.5%#41 M |
| 52-week low | 3 | -3.6%#221 L | -3.3%#226 L | +14.1%#65 L | +36.8%– |
| Crossed above 200-day avg | 7 | -1.4%#364 L | +6.5%#96 L | +1.5%#242 L | +7.4%#186 L |
| Crossed below 200-day avg | 7 | +0.2%#127 L | +3.6%#76 L | +5.4%#46 L | +11.0%#128 L |
| RSI oversold | 4 | +0.7%#236 L | +3.0%#46 L | +8.6%#5 L | +27.9%#103 L |
| RSI overbought | 19 | +0.5%#74 M | -1.4%#412 M | +3.3%#39 M | +11.5%#50 M |
| Reddit spike | 9 | +1.2%#12 M | +0.7%#27 M | +1.1%#45 M | +17.2%#3 M |
| Analyst upgrade | 5 | +0.9%#6 L | +3.6%#3 L | +7.7%#1 L | +29.5%#2 L |
| Analyst downgrade | 4 | +1.9%#3 L | +5.8%#3 L | +18.2%#3 L | +51.9%#1 L |
| Insider buy | — | — | — | — | — |
| Insider unplanned sale | 14 | +1.4%#5 M | +1.6%#12 M | -3.5%#21 L | -3.8%#17 L |
Median gain from the close of the session the event was known, over each holding period; #rank among the S&P 500 stocks after the same kind of event (#1 = best). "Big" is AMAT's own: its worst / best 10% of days over the prior 2 years. Highlighted: happening in the latest session.
52-week high
A new 52-week closing high.
| Holding | Events | Median (likely range) | Confidence | Rank | Up | vs SPY | Range of outcomes (worst · 25–75% · median · best) | vs S&P 500 stocks (their medians) |
|---|---|---|---|---|---|---|---|---|
| 1 day | 19 | +0.21% (-1.0 to +0.8) | Medium | #175 of 482 | 53% | 0.00% |
-3%
+3%
|
|
| 1 week | 19 | -1.11% (-2.9 to +0.1) | Medium | #423 of 482 | 37% | -1.65% |
-9%
+12%
|
|
| 1 month | 19 | +6.80% (-0.3 to +9.2) | Medium | #19 of 480 | 63% | +2.25% |
-10%
+13%
|
|
| 1 quarter | 19 ≈9 indep. | +14.49% (+9.4 to +22.1) | Medium | #41 of 455 | 68% | +9.73% |
-22%
+52%
|
Range of outcomes: all of AMAT's new 52-week highs in the past 5 years, from the worst to the best result over each holding period; the box holds the middle half, the tick is the median. A wide box means the median alone says little. Hover the median for the average.
52-week high by trend
| When it happened | Events | 1 day | 1 week | 1 month | 1 quarter |
|---|---|---|---|---|---|
| Long trendAbove its 200-day avg now | 19 | +0.2%M vs +0.2% | -1.1%M vs +1.0% | +6.8%M vs +3.9% | +14.5%M vs +15.4% |
| Below its 200-day avg | — | — | — | — | — |
| Medium trendAbove its 50-day avg now | 19 | +0.2%M vs +0.2% | -1.1%M vs +0.8% | +6.8%M vs +3.1% | +14.5%M vs +12.0% |
| Below its 50-day avg | — | — | — | — | — |
| Short trendAbove its 20-day avg now | 19 | +0.2%M vs +0.1% | -1.1%M vs +0.4% | +6.8%M vs +2.7% | +14.5%M vs +8.9% |
| Below its 20-day avg | — | — | — | — | — |
The same event split by where AMAT stood against its 200-, 50- and 20-day averages when it happened (a dip in an uptrend vs a falling knife); "vs" is the plain any-day median in that trend; "now" marks where it stands today. Splitting halves the evidence, so watch the confidence letters: H / M / L.
Latest new 52-week highs
| Event | Entry | 1 day | 1 week | 1 month | 1 quarter | |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Jun 11 @ $552.05 | +11.2% on the day | +2.6% | +11.7% | +7.8% | -17.3% |
| May 11, 2026 | May 11 @ $442.60 | +1.9% on the day | -2.8% | -6.8% | +12.2% | +18.6% |
| Apr 9, 2026 | Apr 9 @ $396.89 | +3.1% on the day | +0.4% | -2.0% | +9.5% | +51.6% |
| Feb 13, 2026 | Feb 13 @ $353.65 | +8.1% on the day | +1.2% | +5.4% | -0.6% | +23.2% |
| Jan 9, 2026 | Jan 9 @ $300.11 | +6.9% on the day | +2.0% | +8.6% | +9.3% | +31.6% |
| Dec 4, 2025 | Dec 4 @ $268.48 | +0.3% on the day | -0.5% | +0.2% | +9.9% | +26.0% |
| Nov 3, 2025 | Nov 3 @ $236.40 | +2.0% on the day | -3.2% | -1.1% | +13.2% | +25.4% |
| Oct 1, 2025 | Oct 1 @ $216.54 | +6.3% on the day | +2.7% | -0.1% | +6.8% | +18.3% |
| Jun 17, 2024 | Jun 17 @ $238.58 | +2.5% on the day | +2.0% | -3.5% | -10.4% | -22.2% |
| May 15, 2024 | May 15 @ $213.27 | +3.7% on the day | -1.6% | +0.5% | +9.2% | -2.4% |
| Apr 11, 2024 | Apr 11 @ $208.85 | +1.8% on the day | -2.4% | -8.8% | -1.5% | +14.5% |
| Feb 22, 2024 | Feb 22 @ $195.85 | +4.9% on the day | -1.3% | +0.9% | +5.3% | +9.4% |
| Jan 19, 2024 | Jan 19 @ $164.40 | +4.7% on the day | +0.2% | -0.6% | +12.6% | +13.2% |
| Dec 15, 2023 | Dec 15 @ $158.54 | +0.1% on the day | -1.0% | +0.1% | -1.0% | +24.5% |
| Nov 14, 2023 | Nov 14 @ $150.51 | +2.9% on the day | +0.8% | -3.1% | +5.2% | +22.1% |
Aftermath: entry is the close of the first session the event was fully known (the same session for price moves, the reaction session for earnings, the next session for Reddit, analyst and insider events, which are dated by day). Repeats within a few sessions count as one event. Past performance after an event says nothing certain about the next one. Not advice.